Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

September 26, 2023 02:00 ET | Source: OMass Therapeutics

OMass Therapeutics Adds Mark Namchuk, PhD to Scientific Advisory Board

PRESS RELEASE OMass Therapeutics Adds Mark Namchuk, PhD to Scientific Advisory Board Oxford, United Kingdom – 26th September 2023 – OMass Therapeutics (‘OMass’ or ‘the Company’), a biotechnology...
August 02, 2023 02:00 ET | Source: OMass Therapeutics

OMass Therapeutics Expands Leadership Team with Two New Appointments

PRESS RELEASE OMass Therapeutics Expands Leadership Team with Two New Appointments Appointment of two senior executives in newly created rolesPeter Phillips M.D., Ph.D. joins as Senior Vice...
May 15, 2023 02:00 ET | Source: OMass Therapeutics

OMass Therapeutics Announces Appointment of New Board Chair and Series B Extension

PRESS RELEASE OMass Therapeutics Announces Appointment of New Board Chairand Series B Extension Jim Geraghty joins as Independent Director and Chair, bringing US and international experience from...
April 19, 2023 02:00 ET | Source: OMass Therapeutics

OMass Therapeutics Announces New Phase of Growth with Move to New Facilities and Team Expansion to Support Portfolio Progress

PRESS RELEASE OMass Therapeutics Announces New Phase of Growth with Move to New Facilities and Team Expansion to Support Portfolio Progress Move to new purpose-built 16,000ft2 flagship site on ARC...
November 10, 2022 11:00 ET | Source: OMass Therapeutics

Publication in Nature Chemistry Demonstrates the Benefits of Native Mass Spectrometry in the Interrogation of Target Ecosystems and Drug Discovery

PRESS RELEASE Publication in Nature Chemistry Demonstrates the Benefits of Native Mass Spectrometry in the Interrogation of Target Ecosystems and Drug Discovery Joint publication in Nature...
April 28, 2022 02:00 ET | Source: OMass Therapeutics

OMass Therapeutics Raises $100 Million in Series B Financing to Progress Drug Pipeline in Immunology and Rare Diseases

PRESS RELEASE OMass Therapeutics Raises $100 Million in Series B Financing to Progress Drug Pipeline in Immunology and Rare Diseases Financing led by new investors, GV, Northpond Ventures and Sanofi...
April 06, 2022 11:15 ET | Source: OMass Therapeutics

Publication in Nature by OMass Founder, Professor Dame Carol Robinson, Shows Power of Native Mass Spectrometry in Drug Discovery by Capturing GPCR Signalling in Native Membrane Environment

PRESS RELEASE Publication in Nature by OMass Founder, Professor Dame Carol Robinson, Shows Power of Native Mass Spectrometry in Drug Discovery by Capturing GPCR Signalling in Native Membrane...
March 07, 2022 04:00 ET | Source: OMass Therapeutics

OMass Establishes Scientific Advisory Board of Leading Experts in the Use of Biophysical Approaches to Drug Discovery

PRESS RELEASE OMass Establishes Scientific Advisory Board of Leading Experts in the Use of Biophysical Approaches to Drug Discovery Oxford, United Kingdom – 7 March 2022 – OMass Therapeutics...
February 28, 2022 04:00 ET | Source: OMass Therapeutics

OMass’s OdyssION™ Drug Discovery Platform Makes Progress in Drugging the Undruggable, including Gasdermin D

PRESS RELEASE OMass’s OdyssION™ Drug Discovery Platform Makes Progress in Drugging the Undruggable, including Gasdermin D Oxford, United Kingdom – 28 February 2022 – OMass Therapeutics (‘OMass’ or...
February 21, 2022 04:00 ET | Source: OMass Therapeutics

OMass Therapeutics to Present at Upcoming Conferences

PRESS RELEASE OMass Therapeutics to Present at Upcoming Conferences Oxford, United Kingdom – 21 February 2022 – OMass Therapeutics (‘OMass’ or ‘the Company’), a biotechnology company identifying...